5 results match your criteria: "Rangueil University Hospital Center[Affiliation]"
J Plast Reconstr Aesthet Surg
December 2024
Department of Plastic, Reconstructive and Aesthetic Surgery, Rennes University Hospital Center, Hospital Sud, University of Rennes 1, Rennes, France; INSERM U1236, University of Rennes 1, Rennes, France; SITI Laboratory, Rennes University Hospital, Rennes, France.
Ann Chir Plast Esthet
July 2024
Plastic and Reconstructive Surgery Department, Rangueil University Hospital Center of Toulouse, 1, avenue du Professeur-Jean-Poulhès, 31400 Toulouse, France; Plastic and Reconstructive Surgery Department, Cancer University Institute of Toulouse Oncopole, 1, avenue Hubert-Curien, 31100 Toulouse, France.
Background: Day surgery is developing and its popularity is increasing for a variety of reasons: economic constraints, changes in professional practices, a greater adhesion of the patient. In an era of progress in surgical procedures, pedicled-perforator flaps reducing donor site morbidity and avoiding micro-anastomosis could take their place in Day surgery if planned and managed by an experienced team.
Methods: In the period January 2019 to January 2021, we performed perforator flaps for soft tissue coverage in ambulatory setting.
Surg Radiol Anat
June 2024
Plastic Surgery Department, Habib Bourguiba University Hospital Sfax, Sfax, Tunisia.
Purpose: The tensor fasciae latae (TFL) muscle is supplied by the lateral femoral circumflex artery (LCFA), arising from the deep femoral artery. However, it has been noted that there is also a consistent vascular anastomotic network. The aim of this study was to describe the accessory vascularization of the TFL muscle through a descriptive anatomical study, in order to hypothesize the feasibility of harvesting a TFL flap in the event of an injury to the main pedicle.
View Article and Find Full Text PDFAm J Transplant
October 2019
Formerly Alexion Pharmaceuticals, Boston, Massachusetts.
The presence of preformed donor-specific antibodies in transplant recipients increases the risk of acute antibody-mediated rejection (AMR). Results of an open-label single-arm trial to evaluate the safety and efficacy of eculizumab in preventing acute AMR in recipients of deceased-donor kidney transplants with preformed donor-specific antibodies are reported. Participants received eculizumab as follows: 1200 mg immediately before reperfusion; 900 mg on posttransplant days 1, 7, 14, 21, and 28; and 1200 mg at weeks 5, 7, and 9.
View Article and Find Full Text PDFOrthop Traumatol Surg Res
September 2012
Musculoskeletal Institute, Orthopedic and Traumatologic Surgery Dept, Rangueil University Hospital Center, 1, avenue Jean-Poulhès, TSA 50032, 31059 Toulouse cedex 9, France.
Introduction: Patient information is the requisite first step in securing informed consent ahead of surgery, and is legally mandatory. The study hypothesis was that this information is deficient in a significant proportion of cases. This was tested on a clinical audit.
View Article and Find Full Text PDF